查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679387

醫藥合約銷售組織市場規模、佔有率、趨勢分析報告：按服務、治療領域、最終用途、地區、細分市場預測，2025-2030 年

Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services (Personal, Non-personal Promotion), By Therapeutic Area, By End Use (Pharma, Biopharma Companies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

醫藥合約組織市場的成長與趨勢

根據 Grand View Research, Inc. 的新報告，全球醫藥合約銷售組織市場規模預計到 2030 年將達到 181.4 億美元，2025 年至 2030 年的複合年成長率為 8.83%。

合約銷售組織（CSO）對合約銷售新技術的採用率高、最終用戶對擴大生物製藥和小分子藥物銷售的興趣日益濃厚、降低自我銷售相關成本的需求激增是支持該行業成長的一些關鍵因素。近年來，新藥上市的數量不斷增加。

例如，根據IQVIA的研發趨勢報告，2021年全球將推出84種新的活性物質，較前五年增加一倍。預計全球新藥上市數量的增加將推動合約銷售服務的需求，這可能會支持該行業的成長。處方藥銷售額一直在穩定成長。例如，根據Evaluate Pharma的預測，2021年全球處方藥銷售額將達到1.66兆美元，到2028年將達到1.612兆美元。預計疫情後製藥公司銷售需求的增加將帶動對製藥CSO服務的需求增加。

醫藥合約組織市場報告重點

  • 按服務分類，個人推廣領域將在 2024 年佔據產業主導地位。預計製藥公司研發活動的活性化將導致新藥上市和核准數量的增加，從而推動該領域的成長。
  • 由於製藥公司在銷售產品方面的激烈競爭，推動了對高效團隊支援銷售活動的需求，預計到 2024 年，醫藥終端用途領域將佔據最大的收益佔有率。
  • 2024年，北美將佔據最大的收益佔有率。過去幾年，該地區，尤其是在美國，推出了大量藥物，這是支持該地區成長的關鍵因素之一。
  • 此外，該地區的公共組織也持續增加資金投入，並支持研發活動。這進一步支持了該地區的發展。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章：醫藥合約銷售組織市場：依服務估算與趨勢分析

  • 細分儀表板
  • 醫藥銷售合約組織市場、服務波動分析
  • 醫藥合約銷售組織市場規模與趨勢分析（按服務），2018 年至 2030 年
  • 個人晉升
    • 推廣銷售團隊
    • 大客戶管理
    • 空缺管理
  • 非個人推廣
    • 醫療解決方案
    • 遠端醫療科學聯絡
    • 護理教育者
    • 其他

第5章：醫藥銷售合約組織市場：依治療領域進行的估計與趨勢分析

  • 細分儀表板
  • 醫藥合約銷售組織市場、治療領域變化分析
  • 2018-2030 年醫藥合約銷售組織市場規模及趨勢分析（依治療領域）
  • 腫瘤學
  • 心血管
  • 神經病學
  • 感染疾病
  • 代謝紊亂
  • 整形外科疾病
  • 其他

第6章 醫藥合約組織市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • 醫藥合約組織市場、最終用途趨勢分析
  • 2018 年至 2030 年醫藥合約銷售組織規模及趨勢分析（依最終用途）
  • 製藥公司
  • 生物製藥公司

第7章區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 2018-2030年北美製藥合約組織市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲製藥合約組織市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區醫藥合約分銷組織市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲醫藥合約銷售組織市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲醫藥合約分銷組織市場（2018-2030）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 公司分類
  • 2024年企業市場分析
  • 公司簡介
    • CMIC Holdings Co., Ltd.
    • Axxelus
    • EPS Corp.
    • QFR Solutions
    • MaBico
    • Mednext Pharma Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • IQVIA, Inc.
    • Promoveo Health
    • Syneous Health
Product Code: GVR-4-68040-034-7

Pharmaceutical Contract Sales Organizations Market Growth & Trends:

The global pharmaceutical contract sales organizations market size is estimated to reach USD 18.14 billion by 2030, expanding at a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry. Over the years, the number of new drug launches has increased.

For instance, according to the IQVIA report on R&D trends, 84 new active substances were launched globally in 2021, which was double as compared to the last five years. The increase in drug launches globally is expected to improve the demand for contract sales services, which is likely to support industry growth. Prescription drug sales are witnessing a steady rise. For instance, according to Evaluate Pharma, worldwide total prescription drug sales accounted for USD 1,066 billion in 2021 and will reach USD 1,612 billion by 2028. The growing demand for sales among pharmaceutical companies is expected to improve the demand for CSO services for pharmaceuticals in the post-pandemic period.

Pharmaceutical Contract Sales Organizations Market Report Highlights:

  • Based on service, the personal promotion segment dominated the industry in 2024. A rise in the R&D activities of pharmaceutical companies is expected to increase the number of new drug launches, and approvals are expected to support the segment growth
  • The pharmaceutical companies end-use segment held the largest revenue share in 2024 due to the high competition among pharmaceutical companies in product sales, promoting the demand for an efficient team to support their sales activities
  • North America held the largest revenue share in 2024. A significant number of drugs were launched in the region in the previous years, especially in the U.S., which is one of the key factors supporting the region's growth
  • Moreover, the region's public organization is steadily focused on supporting R&D activities by providing funding. This has further supported the region's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Contract Sales Organizations Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pharmaceutical Contract Sales Organizations Market; Service Movement Analysis
  • 4.3. Pharmaceutical Contract Sales Organizations Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Personal Promotion
    • 4.4.1. Personal promotion market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Promotional sales team
      • 4.4.2.1. Promotional sales team market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Key account management
      • 4.4.3.1. Key account management market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Vacancy management
      • 4.4.4.1. Vacancy management market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Non-personal promotion
    • 4.5.1. Non-personal promotion market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Medical affairs solutions
      • 4.5.2.1. Medical affairs solutions market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Remote medical science liaisons
      • 4.5.3.1. Remote medical science liaisons market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Nurse educators
      • 4.5.4.1. Nurse educators market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pharmaceutical Contract Sales Organizations Market; Therapeutic Areas Movement Analysis
  • 5.3. Pharmaceutical Contract Sales Organizations Market Size & Trend Analysis, by Therapeutic Areas, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cardiovascular
    • 5.5.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Neurology
    • 5.6.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Metabolic Disorders
    • 5.8.1. Metabolic Disorders market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Orthopedic Diseases
    • 5.9.1. Orthopedic Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Sales Organizations Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pharmaceutical Contract Sales Organizations Market; End Use Movement Analysis
  • 6.3. Pharmaceutical Contract Sales Organizations Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceutical Companies
    • 6.5.1. Biopharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Germany pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. UK pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. South Korea pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. CMIC Holdings Co., Ltd.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Axxelus
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. EPS Corp.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. QFR Solutions
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MaBico
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Mednext Pharma Pvt. Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Peak Pharma Solutions Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. IQVIA, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Promoveo Health
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Syneous Health
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Contract Sales Organizations Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 10 North America Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 13 U.S. Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 Canada Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 16 Canada Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Mexico Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 19 Mexico Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 23 Europe Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 25 UK Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 26 UK Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Germany Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 29 Germany Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 31 France Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 32 France Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 34 Italy Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 35 Italy Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 Spain Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 38 Spain Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 40 Denmark Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 41 Denmark Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Sweden Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 44 Sweden Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 Norway Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 47 Norway Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 54 Japan Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 China Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 57 China Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 India Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 60 India Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 Australia Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 63 Australia Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 65 South Korea Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 66 South Korea Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Thailand Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 69 Thailand Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 72 Latin America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 73 Latin America Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 75 Brazil Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 76 Brazil Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 78 Argentina Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 79 Argentina Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 80 MEA Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 82 MEA Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 83 South Africa Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 South Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 85 South Africa Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 90 UAE Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 91 UAE Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Contract Sales Organizations Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Pharmaceutical Contract Sales Organizations Market: Service Key Takeaways
  • Fig. 14 Global Pharmaceutical Contract Sales Organizations Market: Service Movement Analysis
  • Fig. 15 Global Pharmaceutical Contract Sales Organizations Market, for Personal Promotion, 2018 - 2030 (USD Million)
  • Fig. 16 Global Pharmaceutical Contract Sales Organizations Market, for Promotional sales team, 2018 - 2030 (USD Million)
  • Fig. 17 Global Pharmaceutical Contract Sales Organizations Market, for Key account management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Pharmaceutical Contract Sales Organizations Market, for Vacancy Management, 2018 - 2030 (USD Million)
  • Fig. 19 Global Pharmaceutical Contract Sales Organizations Market, for Non-personal promotion, 2018 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceutical Contract Sales Organizations Market, for Medical affairs solutions, 2018 - 2030 (USD Million)
  • Fig. 21 Global Pharmaceutical Contract Sales Organizations Market, for Remote medical science liaisons, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pharmaceutical Contract Sales Organizations Market, for Nurse educators, 2018 - 2030 (USD Million)
  • Fig. 23 Global Pharmaceutical Contract Sales Organizations Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Key Takeaways
  • Fig. 25 Global Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Movement Analysis
  • Fig. 26 Global Pharmaceutical Contract Sales Organizations Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pharmaceutical Contract Sales Organizations Market, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 28 Global Pharmaceutical Contract Sales Organizations Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 29 Global Pharmaceutical Contract Sales Organizations Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 30 Global Pharmaceutical Contract Sales Organizations Market, for Metabolic Disorders, 2018 - 2030 (USD Million)
  • Fig. 31 Global Pharmaceutical Contract Sales Organizations Market, for Orthopedic Diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Pharmaceutical Contract Sales Organizations Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Pharmaceutical Contract Sales Organizations Market: End Use Key Takeaways
  • Fig. 34 Global Pharmaceutical Contract Sales Organizations Market, End Use Movement Analysis
  • Fig. 35 Global Pharmaceutical Contract Sales Organizations Market, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global Pharmaceutical Contract Sales Organizations Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 Regional Outlook, 2024 & 2030
  • Fig. 39 North America Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)